Cost-Effectiveness Analysis of Midostaurin (MIDO) With Standard Chemotherapy (SOC) for Acute Myeloid Leukemia (AML) in the United Kingdom (UK)

Value in Health - United Kingdom
doi 10.1016/j.jval.2017.08.005
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Cn6 - Cost-Effectiveness Model of Midostaurin (Mido) Versus Standard of Care (Soc) in Patients With Newly Diagnosed Flt3 Mutation-Positive (Flt3+) Acute Myeloid Leukemia (Aml): A French Perspective

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Radius: Midostaurin (Mido) Plus Standard of Care (SOC) After Allogeneic Stem Cell Transplant (alloSCT) in Patients (Pts) With FLT3-Internal Tandem Duplication (ITD)–Mutated Acute Myeloid Leukemia (AML)

Biology of Blood and Marrow Transplantation
TransplantationHematology
2019English

Immunologic Consequences of Chemotherapy for Acute Myeloid Leukemia

Journal of Pediatric Hematology/Oncology
Child HealthOncologyPediatricsHematologyPerinatology
2013English

Psy114 - Cost-Effectiveness of Vedolizumab Compared With Conventional Therapy in Patients With Crohn’s Disease in the United Kingdom (Uk)

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Effects of the Multi‐kinase Inhibitor Midostaurin in Combination With Chemotherapy in Models of Acute Myeloid Leukaemia

Journal of Cellular and Molecular Medicine
Molecular MedicineCell Biology
2020English

The Cost-Effectiveness of Supported Employment for Adults With Autism in the United Kingdom

Autism
DevelopmentalEducational Psychology
2013English

Glasdegib Plus Intensive/Nonintensive Chemotherapy in Untreated Acute Myeloid Leukemia: BRIGHT AML 1019 Phase III Trials

Future Oncology
MedicineCancer ResearchOncology
2019English

Strategic Options for Antenatal Screening for Syphilis in the United Kingdom: A Cost Effectiveness Analysis

Journal of Medical Screening
Health PolicyPublic HealthOccupational HealthEnvironmental
2000English

Effect of NPM1 and FLT3 Mutations on the Outcomes of Elderly Patients With Acute Myeloid Leukemia Receiving Standard Chemotherapy

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy